These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9281158)

  • 41. [A method for cleansing suppurative wounds with parotid saliva in the combined treatment of odontogenic phlegmon].
    Khegaĭ SM; Sumanov MB
    Stomatologiia (Mosk); 1987; 66(5):76. PubMed ID: 3480646
    [No Abstract]   [Full Text] [Related]  

  • 42. [The combined treatment of patients with progressive phlegmons of the maxillofacial area].
    Shargorodskiĭ AG; Zabelin AS; Fedorova GG; Baranovskiĭ VA
    Stomatologiia (Mosk); 1998; 77(2):32-4. PubMed ID: 9584590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of hyperbaric oxygenation in the combined treatment of acute inflammatory processes of the soft tissues of the maxillofacial area].
    Kurakin AV; Karapetian IS; Volozhin AI; Sidel'nikova GM; Pomerantseva EN
    Stomatologiia (Mosk); 1982; 61(5):36-8. PubMed ID: 6959389
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of inflammatory pyodestructive processes of the oral cavity, maxillofacial area, and neck by laser and magnetic-laser exposure of the carotid sinus using the Optodan laser apparatus].
    Zhizhina NA; Prokhonchukov AA; Vakhtin VI; Geniuk VIa
    Stomatologiia (Mosk); 2003; 82(3):32-7. PubMed ID: 12841139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hemosorption in the combined therapy of suppurative-septic processes of the maxillofacial area].
    Zakharov IuS; Bolgov DF
    Stomatologiia (Mosk); 1985; 64(3):45-7. PubMed ID: 3863281
    [No Abstract]   [Full Text] [Related]  

  • 46. [The status and outlook for the prevention and treatment of suppurative inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Kozlov VA; Maksimovskiĭ IuM; Robustova TG
    Stomatologiia (Mosk); 1996; Spec No():38. PubMed ID: 9281122
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical results of perftorane use in comprehensive treatment of patients with odontogenic phlegmons].
    Durnovo EA; Furman IV
    Stomatologiia (Mosk); 2007; 86(4):35-9. PubMed ID: 17828096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The use of nitatsid and gipozol'-N in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Tarasenko SV; Aleksashina IP; Agapov VS; Trukhina GM; Liapunov NA
    Stomatologiia (Mosk); 2000; 79(2):17-9. PubMed ID: 10812984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combined treatment of suppurative inflammatory diseases of the maxillofacial area using thymalin].
    Shimchenko PIa; Morozov VG; Khavinson VKh; Orlov VS
    Vestn Khir Im I I Grek; 1981 Oct; 127(10):94-7. PubMed ID: 6895567
    [No Abstract]   [Full Text] [Related]  

  • 50. [Bacteriophage and proteolytic enzymes in the treatment of odontogenic abscesses and phlegmons].
    Kats AG; Biberman IaM; Zabokritskaia DM; Malomud ZP; Starodubtsev VS
    Stomatologiia (Mosk); 1980; 59(2):29-31. PubMed ID: 6445610
    [No Abstract]   [Full Text] [Related]  

  • 51. [Intraosseous administration of thymalin in the combined treatment of children with acute odontogenic osteomyelitis].
    Supiev TK; Galiapin AS; Baĭshulakov AA
    Stomatologiia (Mosk); 1990; 69(1):69-71. PubMed ID: 2326818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Osteoplasty and ozone therapy in the treatment of a severe degree of generalized periodontitis].
    Chuprunova IN
    Stomatologiia (Mosk); 1996; Spec No():90-1. PubMed ID: 9281194
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinico-therapeutic observations on a series of cases of odontogenic abscesses and phlegmons].
    Miconi M; Gallesio C; Berrone S
    Minerva Stomatol; 1991 Oct; 40(10):641-9. PubMed ID: 1803221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maxillofacial cellulitis.
    de-Vicente-Rodríguez JC
    Med Oral Patol Oral Cir Bucal; 2004; 9 Suppl():133-8; 126-33. PubMed ID: 15580131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of a transport medium for isolating asporogenic anaerobes from clinical specimens in odontogenic phlegmon].
    Oleĭnik II; Bychenko BD; Robustova TG; Ushakov RV; Terekhova EV
    Stomatologiia (Mosk); 1984; 63(5):35-7. PubMed ID: 6593913
    [No Abstract]   [Full Text] [Related]  

  • 56. [The status and outlook in the prevention and treatment of suppurative inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Kozlov VA; Robustova TG; Maksimovskiĭ IuM
    Stomatologiia (Mosk); 1997; 76(2):15-9. PubMed ID: 9163076
    [No Abstract]   [Full Text] [Related]  

  • 57. [The prediction of the outcomes of severe odontogenic inflammatory diseases of the maxillofacial area taking into account biorhythms].
    Taĭchenachev AIa
    Stomatologiia (Mosk); 1998; 77(6):15-8. PubMed ID: 10067408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ultrasonic treatment of suppurative wounds in the combined therapy of phlegmons of the face and neck].
    Bazhanov NN; Chikorin AK
    Stomatologiia (Mosk); 1984; 63(1):42-5. PubMed ID: 6369635
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of dissolved ozone in the treatment of experimental tuberculosis in mice].
    Belianin II; Shmelev EI; Martynova LP; Nikonenko BV
    Probl Tuberk Bolezn Legk; 2004; (10):36-9. PubMed ID: 15568319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controversies in the Management of Oral and Maxillofacial Infections.
    Taub D; Yampolsky A; Diecidue R; Gold L
    Oral Maxillofac Surg Clin North Am; 2017 Nov; 29(4):465-473. PubMed ID: 28823889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.